Candriam SCA’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.5M | Buy |
60,901
+24,040
| +65% | +$8.92M | 0.11% | 184 |
|
|
2026
Q1 | $10.8M | Sell |
36,861
-6,979
| -16% | -$2.29M | 0.06% | 271 |
|
|
2025
Q4 | $15.4M | Sell |
43,840
-5,418
| -11% | -$1.83M | 0.08% | 216 |
|
|
2025
Q3 | $15.9M | Sell |
49,258
-18,211
| -27% | -$5.66M | 0.08% | 210 |
|
|
2025
Q2 | $26.2M | Buy |
67,469
+13,638
| +25% | +$5.49M | 0.15% | 129 |
|
|
2025
Q1 | $23.4M | Sell |
53,831
-20,660
| -28% | -$8.29M | 0.15% | 144 |
|
|
2024
Q4 | $27.5M | Sell |
74,491
-38,442
| -34% | -$16.1M | 0.16% | 130 |
|
|
2024
Q3 | $58.7M | Sell |
112,933
-3,267
| -3% | -$1.75M | 0.34% | 65 |
|
|
2024
Q2 | $77M | Buy |
116,200
+36,845
| +46% | +$19.5M | 0.47% | 50 |
|
|
2024
Q1 | $41.1M | Buy |
79,355
+29,267
| +58% | +$14.6M | 0.26% | 86 |
|
|
2023
Q4 | $23.6M | Buy |
50,088
+1,068
| +2% | +$494K | 0.16% | 137 |
|
|
2023
Q3 | $21.3M | Sell |
49,020
-13,019
| -21% | -$5.91M | 0.15% | 136 |
|
|
2023
Q2 | $27.6M | Sell |
62,039
-39,336
| -39% | -$18.1M | 0.2% | 129 |
|
|
2023
Q1 | $42.9M | Sell |
101,375
-7,614
| -7% | -$3.62M | 0.3% | 79 |
|
|
2022
Q4 | $55.9M | Sell |
108,989
-2,487
| -2% | -$1.26M | 0.38% | 64 |
|
|
2022
Q3 | $50.6M | Buy |
111,476
+52,658
| +90% | +$25.2M | 0.36% | 65 |
|
|
2022
Q2 | $28.4M | Buy |
58,818
+3,661
| +7% | +$1.81M | 0.23% | 101 |
|
|
2022
Q1 | $27.1M | Buy |
55,157
+615
| +1% | +$281K | 0.18% | 127 |
|
|
2021
Q4 | $25.3M | Sell |
54,542
-1,808
| -3% | -$761K | 0.16% | 148 |
|
|
2021
Q3 | $21M | Sell |
56,350
-501
| -0.9% | -$190K | 0.14% | 168 |
|
|
2021
Q2 | $21.7M | Sell |
56,851
-10,821
| -16% | -$4.14M | 0.15% | 164 |
|
|
2021
Q1 | $20.9M | Hold |
67,672
| – | – | 0.17% | 142 |
|
|
2020
Q4 | $21.7M | Buy |
67,672
+9,533
| +16% | +$2.93M | 0.17% | 143 |
|
|
2020
Q3 | $15.6M | Buy |
58,139
+18,270
| +46% | +$4.92M | 0.15% | 164 |
|
|
2020
Q2 | $10.5M | Sell |
39,869
-12,812
| -24% | -$3.42M | 0.11% | 213 |
|
|
2020
Q1 | $15.6M | Hold |
52,681
| – | – | 0.17% | 140 |
|
|
2019
Q4 | $15.9M | Sell |
52,681
-1,143
| -2% | -$315K | 0.17% | 140 |
|
|
2019
Q3 | $12.9M | Sell |
53,824
-21,933
| -29% | -$6.01M | 0.17% | 138 |
|
|
2019
Q2 | $21.3M | Buy |
75,757
+8
| +0% | +$2.19K | 0.27% | 82 |
|
|
2019
Q1 | $21.7M | Buy |
75,749
+4,274
| +6% | +$1.24M | 0.28% | 81 |
|
|
2018
Q4 | $18.8M | Buy |
71,475
+5,848
| +9% | +$1.61M | 0.29% | 74 |
|
|
2018
Q3 | $18M | Sell |
65,627
-15,501
| -19% | -$4.02M | 0.24% | 102 |
|
|
2018
Q2 | $19.3M | Sell |
81,128
-1,928
| -2% | -$446K | 0.31% | 77 |
|
|
2018
Q1 | $18.2M | Buy |
83,056
+36,385
| +78% | +$8.55M | 0.31% | 83 |
|
|
2017
Q4 | $10.5M | Sell |
46,671
-14,365
| -24% | -$3.06M | 0.18% | 150 |
|
|
2017
Q3 | $11.6M | Sell |
61,036
-4,288
| -7% | -$816K | 0.2% | 136 |
|
|
2017
Q2 | $12.3M | Buy |
65,324
+26,551
| +68% | +$4.77M | 0.23% | 115 |
|
|
2017
Q1 | $6.41M | Sell |
38,773
-15,150
| -28% | -$2.41M | 0.12% | 201 |
|
|
2016
Q4 | $7.75M | Sell |
53,923
-39,232
| -42% | -$5.25M | 0.18% | 144 |
|
|
2016
Q3 | $11.7M | Buy |
93,155
+52,920
| +132% | +$6.83M | 0.28% | 88 |
|
|
2016
Q2 | $5.29M | Buy |
40,235
+5,264
| +15% | +$720K | 0.14% | 172 |
|
|
2016
Q1 | $4.83M | Buy |
+34,971
| New | +$4.67M | 0.12% | 201 |
|
|
2015
Q4 | – | Sell |
-112,841
| Closed | -$15.8M | – | 601 |
|
|
2015
Q3 | $15.8M | Buy |
112,841
+61,256
| +119% | +$9.21M | 0.39% | 67 |
|
|
2015
Q2 | $8.47M | Sell |
51,585
-32,209
| -38% | -$5.15M | 0.18% | 163 |
|
|
2015
Q1 | $12.9M | Sell |
83,794
-70,656
| -46% | -$10.1M | 0.26% | 106 |
|
|
2014
Q4 | $19.4M | Buy |
+154,450
| New | +$19.1M | 0.41% | 73 |
|
Other funds holding ELV
Candriam SCA's ELV Position: Q2 2026 in Review
Candriam SCA increased its Elevance Health (ELV) stake by 65% in Q2 2026, buying an estimated $8.92M and bringing the position to 60,901 shares worth $23.5M. The position accounts for 0.11% of the portfolio, ranked #184.
Candriam SCA first reported a position in ELV in Q4 2014 and has held it in 46 quarters since. The position peaked at $77M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Candriam SCA held 60,901 shares of Elevance Health worth $23.5M as of Q2 2026.
- Candriam SCA bought 24,040 Elevance Health shares in Q2 2026, an estimated $8.92M.
- Elevance Health made up 0.11% of Candriam SCA's portfolio in Q2 2026, its #184 holding.
- Candriam SCA first reported a position in Elevance Health in Q4 2014 and has held it in 46 quarters since.
- Candriam SCA's Elevance Health position peaked at $77M in Q2 2024.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.